The rate of suicide for people who have had an episode of parasuicide is 100 times higher in the year following the episode than that of the general population. 1 Providing a high standard of care to patients who deliberately harm themselves could help to reduce this rate.2 Long term follow up studies show that the increased rate of suicide persists.3 However, the long term risk of suicide in patients in the United Kingdom is uncertain. We traced a consecutive sample of patients 22 years after they presented to a central London teaching hospital after an episode of parasuicide in the late 1970s. Method and resultsFrom May 1977 to March 1980 one of us (RH) collected demographic and clinical data on a consecutive sample of weekday ward referrals to psychiatric services after patients had an episode of parasuicide. Twenty two years later we attempted to trace the patients, using data from the Office for National Statistics. In accordance with previous studies we combined deaths that were recorded as "suicide" with deaths in which data on the death certificate suggested that the cause of death was "probable suicide." 4 Cause of death was attributed to probable suicide by two raters (GRJ and MP) independently, and there was full agreement between these two sets of ratings. Data were analysed by using the statistical software package SPSS (version 9.0). The rate of suicide during the period of follow up was calculated and then illustrated by using survival curves. We examined longitudinal associations between subsequent suicide and potential explanatory factors by using Cox regression. Hazard ratios with 95% confidence intervals are presented.A total of 223 patients were interviewed between May 1977 and March 1980. Most (154, 69%) were women, with a mean age of 32 years. Basic demographic details required by the Office for National Statistics to trace patients had been recorded for 180 patients, 40 of whom could not be traced. The characteristics of the 140 who were traced and the 83 not traced were similar. However, patients who were not traced were more likely to come from ethnic minorities and more likely to have consumed alcohol at the time of parasuicide than patients who were traced (25% v 9%, difference in proportions 18% (95% confidence interval 12% to 38%) and 28% v 16%, 12% (2% to 24%), respectively). The remaining 140 were followed until July 2000 (mean follow up 21.75 years, range 20.3-23.1 years). During this period 25 (18%) died. Examination of death certificates revealed three suicides and nine probable suicides (four were recorded as open verdict and five as accidental death). The overall rate of probable suicide was 4.3 (2.4 to 7.7) per 1000 per year.The figure illustrates the rate of survival from suicide plus probable suicide during the period of follow up. The rate was 5.9/1000/year in the first five years, 0/1000/year between five and 10 years, 4.7/1000/year between 10 and 15 years, 5.0/1000/ year between 15 and 20 years, and 6.8/1000/year in the final three years. The rate did not decline wit...
Background: Abnormal bodily sensations, ‘cenesthesias’, are frequently described psychopathological symptoms in schizophrenia. ‘Cenesthopathic schizophrenia’ is included but undefined within the category ‘other schizophrenia’ (F20.8) in the ICD-10 classification. Method: This narrative review pursues the development of the concept of cenesthopathic schizophrenia, from its foundation in the late 18th century to the present (phenomenology of cenesthesias). It explores its applicability and relevance as a diagnostic entity in psychiatry today. The review is based on a critical reading of papers identified through Medline (1951 to date), Psychinfo (1887 to date) and EMBASE (1974 to date) searches (using subject headings: cenesthesias, cenesthopathy, cenesthopathic schizophrenia) as well as a hand-search of related references in selected papers. Results: Current knowledge supports the notion of a distinct subgroup of schizophrenia patients with marked and dominating abnormal bodily sensations. Conclusions: Further research is necessary to identify other characteristics of the subgroup, to clarify the neurobiological and psychological basis of the phenomena and to determine as to whether the subgroup benefits from distinct treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.